It is reported that miR-199a/b-5p enhances imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells [44]. Here, WNT2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.